Filing Details
- Accession Number:
- 0001375151-20-000155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 17:05:48
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2020-11-18 17:05:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375151 | Zogenix Inc. | ZGNX | Pharmaceutical Preparations (2834) | 205300780 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543174 | P Renee Tannenbaum | C/O Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville CA 94608 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-17 | 15,000 | $20.74 | 32,872 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected to satisfy certain tax obligations of the Reporting Person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.69 to $20.80, inclusive. The Reporting Person undertakes to provide to Zogenix, Inc., any security holder of Zogenix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
